Who have Amaurosis with Breast cancer - from FDA reports

Amaurosis is reported only by a few people with Breast cancer. We study 2 people who have Amaurosis and Breast cancer from FDA . Find out below who they are, other conditions they have and drugs they take.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.

On Dec, 10, 2018

2 people who have Breast Cancer and Amaurosis are studied.

Number of reports submitted per year:

Would you have Amaurosis when you have Breast cancer?

Gender of people who have Breast Cancer and experience Amaurosis *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Breast Cancer and experience Amaurosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 50 %
  • 40-49: 50 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top co-existing conditions for these people *:

  1. Metastases To Lung (cancer spreads to lung): 1 person, 50.00%
  2. Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 50.00%
  3. Metastases To Bone (cancer spreads to bone): 1 person, 50.00%

Most common drugs for these people *:

  1. Zometa: 1 person, 50.00%
  2. Xeloda: 1 person, 50.00%
  3. Taxotere: 1 person, 50.00%
  4. Neulasta: 1 person, 50.00%
  5. Epirubicin Hydrochloride: 1 person, 50.00%

Click here to view more results

Top symptoms for these people *:

  1. Visual Field Defect: 1 person, 50.00%
  2. Swallowing Difficulty: 1 person, 50.00%
  3. Speech Impairment (Adult) (inability to speak (adult)): 1 person, 50.00%
  4. Speech Disorder: 1 person, 50.00%
  5. Optic Neuritis (optic nerve inflammation): 1 person, 50.00%

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you have Amaurosis with Breast cancer?

You are not alone:

Related studies

Breast Cancer

Breast cancer can be treated by Arimidex, Tamoxifen citrate, Femara, Letrozole, Anastrozole (latest reports from 130,923 Breast cancer patients)


Amaurosis (partial or total blindness without visible change in the eye) has been reported by people with rheumatoid arthritis, stress and anxiety, malaria, high blood pressure, type 2 diabetes (latest reports from 456 Amaurosis patients).

Drugs that are associated with Amaurosis
Amaurosis (257 drugs)
Other conditions that could cause Amaurosis
Amaurosis (175 conditions)
Browse all symptoms of Breast cancer
a b c d e f g h i j k l m n o p q r s t u v w x y z

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!